Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.

Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E.

Arch Neurol. 2008 Oct;65(10):1353-7. doi: 10.1001/archneur.65.10.1353.

2.

The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.

DePaolo J, Goker-Alpan O, Samaddar T, Lopez G, Sidransky E.

Mov Disord. 2009 Aug 15;24(11):1571-8. doi: 10.1002/mds.22538. Review.

3.

The association between ß-glucocerebrosidase mutations and parkinsonism.

Swan M, Saunders-Pullman R.

Curr Neurol Neurosci Rep. 2013 Aug;13(8):368. doi: 10.1007/s11910-013-0368-x. Review.

4.

Exploring the link between glucocerebrosidase mutations and parkinsonism.

Westbroek W, Gustafson AM, Sidransky E.

Trends Mol Med. 2011 Sep;17(9):485-93. doi: 10.1016/j.molmed.2011.05.003. Epub 2011 Jul 1. Review.

5.

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.

Beavan MS, Schapira AH.

Ann Med. 2013 Dec;45(8):511-21. doi: 10.3109/07853890.2013.849003. Review.

PMID:
24219755
6.

Gaucher disease: complexity in a "simple" disorder.

Sidransky E.

Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15. Review.

PMID:
15464415
7.

The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.

Velayati A, Yu WH, Sidransky E.

Curr Neurol Neurosci Rep. 2010 May;10(3):190-8. doi: 10.1007/s11910-010-0102-x. Review.

8.

The significance of GBA for Parkinson's disease.

Brockmann K, Berg D.

J Inherit Metab Dis. 2014 Jul;37(4):643-8. doi: 10.1007/s10545-014-9714-7. Epub 2014 Jun 4. Review.

PMID:
24894157
9.

Gaucher-Associated Parkinsonism.

Li Y, Li P, Liang H, Zhao Z, Hashimoto M, Wei J.

Cell Mol Neurobiol. 2015 Aug;35(6):755-61. doi: 10.1007/s10571-015-0176-8. Epub 2015 Mar 29. Review.

10.

The link between the GBA gene and parkinsonism.

Sidransky E, Lopez G.

Lancet Neurol. 2012 Nov;11(11):986-98. doi: 10.1016/S1474-4422(12)70190-4. Review.

11.

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.

Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E.

Hum Mutat. 2000;15(2):181-8. Review.

PMID:
10649495
12.

Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain.

Alfonso P, Aznarez S, Giralt M, Pocovi M, Giraldo P; Spanish Gaucher's Disease Registry..

J Hum Genet. 2007;52(5):391-6. Epub 2007 Apr 11. Review.

PMID:
17427031
13.

Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.

Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, Ferreira P.

Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. Epub 2006 Dec 29. Review.

PMID:
17196853
14.

Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology.

Kiferle L, Giuntini M, Bonuccelli U, Ceravolo R.

Neurodegener Dis. 2015;15(5):271-80. doi: 10.1159/000433438. Epub 2015 Jul 28. Review.

PMID:
26227893
15.

Glucocerebrosidase mutations among African-American patients with type 1 Gaucher disease.

Park JK, Koprivica V, Andrews DQ, Madike V, Tayebi N, Stone DL, Sidransky E.

Am J Med Genet. 2001 Mar 1;99(2):147-51. Review.

PMID:
11241475
16.

Parkinson's disease.

Lees AJ, Hardy J, Revesz T.

Lancet. 2009 Jun 13;373(9680):2055-66. doi: 10.1016/S0140-6736(09)60492-X. Review. Erratum in: Lancet. 2009 Aug 29;374(9691):684.

PMID:
19524782
17.

Gaucher disease: insights from a rare Mendelian disorder.

Sidransky E.

Discov Med. 2012 Oct;14(77):273-81. Review.

18.

Gaucher disease and comorbidities: B-cell malignancy and parkinsonism.

Cox TM, Rosenbloom BE, Barker RA.

Am J Hematol. 2015 Jul;90 Suppl 1:S25-8. doi: 10.1002/ajh.24057. Review.

Supplemental Content

Support Center